跳至主要内容
临床试验/IRCT201306086280N2
IRCT201306086280N2已完成未知

Comparison of the incidence and severity of cognitive impairment after electroconvulsive therapy under general anesthesia in the two groups with remifentanil- thiopental sodium thiopental - placebo in patients referred to ECT Center shafa of Rasht in 2013

Guilan University of Medical Sciences,Research and Technology0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • patients with psychiatric disorders diagnosed by psychiatrists according to DSMIV-TR criteria; age between 18-60 years old; signing informed consent; ASA physical status I or II; ECT candidates for the first time.
  • Exclusion criteria: emergency ECT; severe cognitive dysfunction prior to ECT; history of mental retardation; severe heart disease; history of previous ECT; ASA physical status III-IV; uncontrolled hypertension and needs to treat agitation after ECT.

排除标准

  • 未提供

研究者

发起方
Guilan University of Medical Sciences,Research and Technology

相似试验